Ph 2/3 Study in Subjects With MPM to Assess ADI-PEG 20 With Pemetrexed and Cisplatin

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

249

Participants

Timeline

Start Date

August 1, 2017

Primary Completion Date

August 15, 2022

Study Completion Date

August 15, 2022

Conditions
Mesothelioma
Interventions
DRUG

ADI-PEG 20 plus Pem Platinum

Investigational Drug in combination approved standard of care treatment for this indication

OTHER

Placebo plus Pem Platinum

Placebo in combination approved standard of care treatment for this indication

Trial Locations (45)

112

Taipei Veterans General Hospital, Taipei

407

Taichung Veterans General Hospital, Taichung

807

Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City

2050

Chris O'Brien Lifehouse, Camperdown

2486

Tweed Hospital (NNSW LHD), Tweed Heads

3084

Austin Health, Heidelberg

4102

Princess Alexandria Hospital and Health Services, Woolloongabba

5042

Southern Adelaide Local Health Network, Inc., Bedford Park

6009

Sir Charles Gairdner Hospital, Perth

10002

National Taiwan University Hospital, Taipei

10065

Memorial Sloan Kettering Cancer Center, New York

15121

SS. Antonio e Biagio e Cesare Arrigo Hospital, Alessandria

16149

Ospedale Villa Scassi, Genova

20133

Fondazione IRCCS - Istituto Nazionale dei Tumori Milano, Milan

20141

European Institute of Oncology, Milan

20900

Azienda Ospedaliera San Gerardo - Monza, Chirurgia Toracica, Monza

21201

University of Maryland, Marlene & Stewart Greenebaum Comprehensive Cancer Center, Baltimore

24125

Humanitas Gavazzeni, Bergamo

27100

Fondazione IRCCS Policlinico San Matteo, Pavia

33305

Chang Gung Memorial Foundation LinKou Branch, Taoyuan District

33612

H. Lee Moffitt Cancer Center & Research Institute, Tampa

43126

Azienda Ospedaliero Universitaria di Parma, Parma

48202

Henry Ford Hospital, Detroit

55905

Mayo Clinic, Rochester

56124

Azienda Ospedaliero Universitaria Pisana, Pisa

60637

University of Chicago, Chicago

77030

MD Anderson Cancer Center, Houston

83301

Chang Gung Medical Foundation Kaohsiung, Kaohsiung City

85054

Mayo Clinic, Phoenix

90095

UCLA Hematology & Oncology - Santa Monica, Los Angeles

94115

University of California San Francisco Helen Diller Comprehensive Cancer Center, San Francisco

CB20QQ

Addenbrooke's Hospital, Cambridge

PL6 8DH

Plymouth Hospitals (Derriford Hospital), Plymouth

EC1M 6BQ

Centre for Experimental Cancer Medicine (CECM), London

SO16 6YD

Southampton General Hospital, Southampton

LE1 5WW

University Hospitals Leicester, Leicester

DN15 7BH

Scunthorpe General Hospital, Scunthorpe

NE63 9JJ

Wansbeck General Hospital, Ashington

OX3 7LE

Oxford Cancer and Haematology Centre, The Churchill Hospital, Oxford

CF14 2TL

Velindre Cancer Centre, Cardiff

EH4 2XU

Edinburgh Cancer Centre, Edinburgh

G12 0YN

Beatson West of Scotland Cancer Centre, Glasgow

LS9 7TF

St James's University Hospital, Leeds

EC1A 7BE

St Bartholomew's Hospital, London

M23 9LT

University Hospital of South Manchester, Manchester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Polaris Group

INDUSTRY